On CNBC's “Mad Money Lightning Round,” Jim Cramer said Fortinet, Inc. FTNT is not his favorite. He added that we own Palo Alto Networks, Inc. PANW for the charitable trust.
On July 11, Barclays analyst Saket Kalia maintained Fortinet with an Equal-Weight and lowered the price target from $75 to $70.
When asked about Air Products and Chemicals, Inc. APD, Cramer said Linde plc LIN is a “much better run company, and that's why Air Products isn't doing as well, and Linde's doing spectacularly.”
On July 16, Air Products named Eric Guter as vice president of Investor Relations effective Sept. 30 succeeding Sidd Manjeshwar.
Sarepta Therapeutics, Inc. SRPT is a “speculative situation where they have great science. I am never going to bet against a biotech company with great science, therefore I bless owning the stock. It's too risky for me, but it's ok if you want to be there,” he said.
On July 1, Piper Sandler analyst Biren Amin maintained Sarepta Therapeutics with an Overweight rating and maintained a $205 price target.
The “Mad Money” host recommended not selling Match Group, Inc MTCH as “you've just got a very, very smart investor in there. You've got Starboard, there's been other activists there too… and Match has to make the changes that Starboard recommends.”
Starboard Value sent a letter to Match Group's CEO, CFO, president and board of directors outlining actionable opportunities for enhancing shareholder value. Starboard Value holds a 6.6% stake in the company, making it the third-largest shareholder.
BJ’s Wholesale Club Holdings, Inc BJ is very good, Cramer said. “My problem is, why would I want the very good when I can get the best, which, of course, is Costco COST.”
On July 11, Loop Capital analyst Laura Champine maintained BJ’s Wholesale with a Hold and raised the price target from $80 to $85.
When asked about Toast, Inc. TOST, he said, “The problem with that is that you are investing in retail by doing that, and I do not want to be as exposed to retail right now, and so that's the only reason why I do not want to own the stock of Toast.”
Toast reported robust performance for the quarter ended March 31 on May 7.
Cramer said Teva Pharmaceutical Industries Limited TEVA is ok, but he likes best of breed. i.e. Eli Lilly LLY.
Teva Pharmaceutical said it will release second-quarter financial results on Wednesday, July 31.
Viking Therapeutics, Inc. VKTX is “terrific,” Cramer said. “I would put Royal Caribbean RCL and Viking at the top of the heap. They are both excellent.”
On June 27, Morgan Stanley analyst Michael Ulz initiated coverage on Viking Therapeutics with an Overweight rating and announced a price target of $105.
Price Action:
- Fortinet shares fell 0.7% to settle at $59.48 on Tuesday.
- Teva shares fell 2.5% to close at $16.65 on Tuesday.
- Viking shares fell 4% to settle at $57.00 during Tuesday's session.
- BJ's Wholesale shares gained 1.4% to $91.38.
- Toast shares gained 5.3% to settle at $27.30 on Tuesday.
- Air Products shares gained 3% to close at $267.53 during Tuesday's session.
- Sarepta shares fell 2.4% to close at $148.98 on Tuesday.
- Match shares gained 7.5% to settle at $34.41 on Tuesday.
Read Next:
Photo: s_bukley/Shutterstock.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
